Ajmalicine
CAS No. 483-04-5
Ajmalicine( Raubasine | Delta-Yohimbine | Ajmalicin | Lamuran )
Catalog No. M28573 CAS No. 483-04-5
Ajmalicine (Raubasine) is a potent adrenolytic agent which preferentially blocks α1-adrenoceptor. Ajmalicine is an reversible but non-competitive nicotine receptor full inhibitor, IC50 = 72.3 μM. Ajmalicine also can be used as anti-hypertensive, and serpentine, with sedative activity。
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 151 | In Stock |
|
| 5MG | 255 | In Stock |
|
| 10MG | 380 | In Stock |
|
| 25MG | 619 | In Stock |
|
| 50MG | 861 | In Stock |
|
| 100MG | 1161 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAjmalicine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAjmalicine (Raubasine) is a potent adrenolytic agent which preferentially blocks α1-adrenoceptor. Ajmalicine is an reversible but non-competitive nicotine receptor full inhibitor, IC50 = 72.3 μM. Ajmalicine also can be used as anti-hypertensive, and serpentine, with sedative activity。
-
DescriptionAjmalicine (Raubasine) is a potent adrenolytic agent which preferentially blocks α1-adrenoceptor. Ajmalicine is an reversible but non-competitive nicotine receptor full inhibitor, IC50 = 72.3 μM. Ajmalicine also can be used as anti-hypertensive, and serpentine, with sedative activity。(In Vitro):Ajmalicine preferentially blocks α1-adrenoceptor than α2-adrenoceptor. Ajmalicine inhibits contractions in a concentration-dependent manner, IC50=72.3 ± 22.5 μM. Ajmalicine acts preferentially at postsynaptic sites, competitively antagonizes the effect of noradrenaline on postsynaptic alpha-adrenoceptor with a pA2 value of 6.57, blocks the inhibitory effect of clonidine with an pA2 value of 6.2.(In Vivo):Ajmalicine blocks the pressor action of electrical stimulation and is active against sympathetic stimulation. Ajmalicine (0.5-4 mg/kg) induces a marked dose-dependent inhibition against the pressor response to noradrenaline.
-
In VitroAjmalicine preferentially blocks α1-adrenoceptor than α2-adrenoceptor.Ajmalicine inhibits contractions in a concentration-dependent manner (IC50=72.3 ± 22.5 μM).Ajmalicine acts preferentially at postsynaptic sites, competitively antagonizes the effect of noradrenaline on postsynaptic alpha-adrenoceptor with a pA2 value of 6.57, blocks the inhibitory effect of clonidine with an pA2 value of 6.2.
-
In VivoAjmalicine blocking the pressor action of electrical stimulation and is active against sympathetic stimulation.Ajmalicine (0.5-4 mg/kg) induces a marked dose-dependent inhibition against the pressor response to noradrenaline. Animal Model:Male Wistar rats (300-350 g)Dosage:0.5, 1, 2, and 4 mg/kg Administration:IV, once Result:Induced a marked dose-dependent inhibition against the pressor response to noradrenaline.
-
SynonymsRaubasine | Delta-Yohimbine | Ajmalicin | Lamuran
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
Recptorp53
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number483-04-5
-
Formula Weight352.43
-
Molecular FormulaC21H24N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 5.56 mg/mL (15.78 mM)
-
SMILES[H][C@@]12C[C@]3([H])C(=CO[C@@H](C)[C@@]3([H])CN1CCc1c2[nH]c2ccccc12)C(=O)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Choudhary A, et al. Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer. Mol Cancer Ther. 2016 Jan;15(1):48-59.
molnova catalog
related products
-
Diosgenin glucoside
Diosgenin glucoside and other synthetic glycosides with similar activities may be of use in the management of hypercholesterolemia and atherosclerosis.
-
2,4'-Dihydroxybenzop...
2,4-dihydroxybenzophenone (BP-1) can effectively protect C57BL/6J mice from APAP-induced hepatotoxicity.
-
JNJ-63533054
JNJ-63533054 is a potent and selective agonist of hGPR139 with an EC50 = 16 nM.
Cart
sales@molnova.com